{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:08:54Z","timestamp":1793686134933,"version":"4.5.1"},"reference-count":64,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T00:00:00Z","timestamp":1395964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatology"],"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Methotrexate has shown efficacy for the treatment of several diseases, especially rheumatoid arthritis (RA). Methotrexate has also been implicated as a causative agent in interstitial lung disease. Patients with RA may develop pulmonary manifestations of their disease and are at increased risk of respiratory infection. The aim of this study was to evaluate the relative risk (RR) of pulmonary disease among patients with RA treated with methotrexate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched the PubMed and Cochrane databases (publication dates January 1, 1990 to February 1, 2013) for double\u2010blind, randomized, controlled trials of methotrexate versus placebo or active comparator agents in adults with RA. Studies with &lt;100 subjects or with a duration of &lt;24 weeks were excluded. Two investigators independently searched both databases, and all of the investigators reviewed the selected studies. We compared differences in the RR using the Mantel\u2010Haenszel random\u2010effects method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 22 studies with 8,584 participants met the inclusion criteria. Heterogeneity across studies was not significant (I<jats:sup>2<\/jats:sup> = 3%), allowing combination of the trial results. Methotrexate was associated with an increased risk of all adverse respiratory events (RR 1.10, 95% confidence interval [95% CI] 1.02\u22121.19) and respiratory infection (RR 1.11, 95% CI 1.02\u22121.21). Patients treated with methotrexate were not at increased risk of death due to lung disease (RR 1.53, 95% CI 0.46\u22125.01) or noninfectious respiratory events (RR 1.02, 95% CI 0.65\u22121.60). A subgroup analysis of studies in which pneumonitis was described revealed an increased risk associated with methotrexate (RR 7.81, 95% CI 1.76\u221234.72).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study demonstrated a small but significant increase in the risk of lung disease in patients with RA treated with methotrexate compared with other disease\u2010modifying antirheumatic drugs and biologic agents.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.38322","type":"journal-article","created":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T08:16:44Z","timestamp":1387873004000},"page":"803-812","source":"Crossref","is-referenced-by-count":225,"title":["Methotrexate and Lung Disease in Rheumatoid Arthritis: A Meta\u2010Analysis of Randomized Controlled Trials"],"prefix":"10.1002","volume":"66","author":[{"given":"Richard","family":"Conway","sequence":"first","affiliation":[{"name":"Galway University Hospitals, Merlin Park Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Low","sequence":"additional","affiliation":[{"name":"St. James's Hospital Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Coughlan","sequence":"additional","affiliation":[{"name":"Galway University Hospitals, Merlin Park Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"O'Donnell","sequence":"additional","affiliation":[{"name":"National University of Ireland Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Carey","sequence":"additional","affiliation":[{"name":"Galway University Hospitals, Merlin Park Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,3,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0240-3"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep252"},{"key":"e_1_2_6_4_1","first-page":"1196","article-title":"All\u2010cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database","volume":"30","author":"Watson DJ","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_6_5_1","first-page":"S35","article-title":"Mortality in rheumatoid arthritis: 2008 update","volume":"26","author":"Sokka T","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23721"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.126532"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27405"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2012.642362"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(87)90021-7"},{"key":"e_1_2_6_11_1","first-page":"1850","article-title":"Adverse effects of low dose methotrexate therapy in rheumatoid arthritis","volume":"20","author":"McKendry RJ","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197609000-00002"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.093690"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1758-6"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken356"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.4.377"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(84)90236-7"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70052-8"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/archderm.1978.01640240042014","article-title":"Progressive interstitial lung disease from prolonged methotrexate therapy","volume":"114","author":"Kaplan RL","year":"1978","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.3.262"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.109.4.933"},{"issue":"2","key":"e_1_2_6_22_1","first-page":"S145","article-title":"Pulmonary function after methotrexate in rheumatoid arthritis: a one\u2010year follow up study","volume":"41","author":"Saravanan V","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2010.04.003"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.10.596"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.4.811"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.2.9609016"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20765"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401016"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/94.6.309"},{"key":"e_1_2_6_30_1","first-page":"1164","article-title":"Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors: four case reports and a review of the literature","volume":"14","author":"Searles G","year":"1987","journal-title":"J Rheumatol"},{"key":"e_1_2_6_31_1","volume-title":"Review Manager (RevMan) [Computer program]. Version 5.1","year":"2011"},{"key":"e_1_2_6_32_1","volume-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]","author":"Higgins JP","year":"2011"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-010-0405-4"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.116319"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.105197"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2870"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24638"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24643"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-008-0125-1"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0681-x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23824"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068064"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21655"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21519"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032534"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432201"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.6.655"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.10.1082"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)01300-7"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.3.345"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605163342002"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350304"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330305"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37723"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.6.712"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep050"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.057133"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/29.3.222"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.11.028"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker289"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker309"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2001.t01-1-00223.x"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.2.272"}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.38322","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.38322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:35:10Z","timestamp":1759937710000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.38322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,28]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1002\/art.38322"],"URL":"https:\/\/doi.org\/10.1002\/art.38322","archive":["Portico"],"relation":{},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,28]]}}}